[Primary stress-induced myocardial disorders and arrhythmic heart disease. Part I].
Meerson
F Z
FZ
D000222:Adaptation, Physiological / Q000187:drug effects; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000465:Algorithms; D000595:Amino Acid Sequence; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D006334:Heart Function Tests; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects; D008969:Molecular Sequence Data; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D013315:Stress, Psychological / Q000150:complications*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists
Pervichnoe stressornoe povrezhdenie miokarda i aritmicheskaia bolezn serdtsa. Chast I.